Kaempferol acts as a potential therapeutic agent for the treatmentof DCM, as it can prevent diabetes-induced inflammation, oxidative stress,myocardial fibrosis, and apoptosis, mechanically linked to the inhibition ofNF-κB and Nrf-2 signaling pathway activation [59]. Here, NFE2L2 is linked to Myocardial fibrosis.